article thumbnail

Robert Whitaker Answers Reader Questions on Mad in America, the Biopsychosocial Model, and Psychiatric History

Mad in America

You sent some great questions and on this and our next podcast, we will be talking with Bob about Mad in America, the biopsychosocial model, the history of psychiatry, pharmaceutical marketing, and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy. But do patients report the same?

article thumbnail

Is Madness an Evolved Signal? Justin Garson on Strategy Versus Dysfunction

Mad in America

Moore: And of course, it was an open door then for the pharmaceutical industry, wasn’t it, with their massive marketing dollars. And I think she’s right that medical psychiatry and the pharmaceutical companies needed a vision like that. You should take a biopsychosocial approach to these various diseases.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Robert Whitaker Answers Reader Questions on Pharma Marketing and Psychiatric Drugs

Mad in America

In Part 1 , we discussed Mad in America, the biopsychosocial model and the history of psychiatry. For Part 2, we will be covering reader questions on pharmaceutical marketing and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy. Does pharma take the same approach, do you believe?

article thumbnail

Decolonizing Psychiatry in Pakistan: A Reckoning with our Colonial Past and a Call for Reconstruction

Mad in America

Yousaf Raza Illicit Ties with the Pharmaceutical Industry Prescribing more medications than are justified is the number-one crime of which a shamefully large number of psychiatrists are guilty. The answer is simple: it is also the standard that pharmaceutical companies hold us to. This is where the kickbacks come from.